NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement
In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine
Consensus Panel Say Surgery, Radiation Both Effective For Clinically Local Prostate Cancer
Bristol To Support Grants For Studies On Drug Resistance
DCT Board Approves Concept For BRMP Master Agreement
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO
